Davangere Sugar FCCB Listing: Terms, Dilution in 2026

What Davangere Sugar disclosed in July 2026

Davangere Sugar Company Limited has made a series of disclosures in July 2026 focused on fundraising and capital restructuring. The company approved and later listed Unsecured Foreign Currency Convertible Bonds (FCCBs), announced a sizeable capital infusion into its UK subsidiary, and scheduled a board meeting to consider additional fundraising options.

The set of actions matters for investors because the financing instruments include equity conversion features. The conversion price disclosed for the FCCBs is close to the stock’s recent trading levels, which brings dilution risk into focus.

Board meeting on July 28: warrants-led fundraising on the agenda

The company said its Board of Directors is scheduled to meet on July 28, 2026. The agenda includes considering raising funds through convertible warrants and or other eligible securities.

In the same July 28 context, the company also indicated that it has agreed to convert loans into equity shares or convertible warrants as part of a capital restructuring exercise. The source alert described this as part of a plan to restructure outstanding debt through equity-linked instruments.

FCCB approval: what the board cleared on July 3

Davangere Sugar disclosed that its board approved an FCCB issuance totalling USD 100 million at its July 3, 2026 meeting. The company also set July 3, 2026 as the “Relevant Date” for determining the regulatory floor price for conversion into equity.

The FCCBs were described as unsecured, with a conversion option into equity shares. The conversion price disclosed is INR 3.60 per equity share.

Issue timeline: opening, allotment, and listing

As per the disclosures, the FCCB issue was scheduled to open on July 6, 2026. The board later approved the allotment of the FCCBs after receipt of subscription money.

The allotment decision was taken at a board meeting held on July 9, 2026. The company confirmed it received subscription money aggregating to USD 85 million for the bonds, against an overall issue size of USD 100 million.

Separately, the company disclosed that it listed FCCBs worth USD 100 million on the Afrinex Stock Exchange in Mauritius, effective July 9, 2026.

Key FCCB terms: coupon, discount, maturity, and conversion

Davangere Sugar’s filings spell out the commercial terms of the FCCBs. The bonds carry a coupon rate of 2% per annum and have a 5-year tenure, maturing on July 9, 2031.

The bonds were issued at a 15% discount to principal, with the aggregate issue price stated as USD 85 million. The company disclosed the conversion price into equity at INR 3.60 per share.

The company also indicated an estimated potential equity dilution of approximately 2.64 billion shares based on the disclosed conversion terms. One disclosure quantified this as approximately 2,645,577,778 equity shares upon full conversion.

Conversion mechanics and the rupee equivalent disclosed

The company explained that the number of equity shares underlying the FCCBs on conversion will be calculated by dividing the nominal amount of each FCCB, converted into rupees at the prevailing exchange rate, by the conversion price of INR 3.60 per equity share.

Using an exchange rate of 95.2408 as on July 3, 2026 (sourced from the Reserve Bank of India, as stated), the USD 100 million issue would translate to approximately INR 9,524,080,000. Based on the same exchange rate and conversion price, the number of equity shares underlying all the FCCBs was disclosed as approximately 264,55,77,778.

UK subsidiary investment: Aurevant Global capital injection

Davangere Sugar also announced an overseas capital allocation tied to the FCCB proceeds. The company approved a USD 84.95 million investment in its wholly owned UK subsidiary, Aurevant Global Limited, aimed at expanding ethanol and sugar products operations.

The disclosure said the capital injection was executed on July 25, 2026 and utilises proceeds from recently allotted Unsecured FCCBs. In return, Davangere Sugar will be allotted approximately 62,463,235 new ordinary shares of GBP 1.00 each.

The transaction note also mentioned an exchange rate of 1.36 GBP per USD for the allotment.

Market snapshot: stock price near the conversion level

One market update in the provided text stated that Davangere Sugar closed up 0.28% at INR 3.57 in the post-market session.

With the FCCB conversion price disclosed at INR 3.60 per share, the proximity between the stock price and the conversion price is a central investor consideration. The same market snapshot also highlighted that the persistent threat of equity dilution could cap near-to-medium-term valuation upside, given the scale of potential shares on conversion.

Approvals and listing details: exchanges and ISIN

Davangere Sugar disclosed that the FCCB issuance received in-principle approval from BSE Limited and the National Stock Exchange of India Limited on June 10, 2026.

For the Afrinex listing, the company disclosed that the listing effective July 9, 2026 covers an aggregate principal amount of USD 100 million. It also shared the ISIN for the listed securities as MU00000000388.

Summary table: key facts from the disclosures

Why the sequence matters for shareholders

The July disclosures show that Davangere Sugar is using multiple levers at once: international convertible debt, a sizeable overseas subsidiary investment funded from bond proceeds, and a proposed warrants-led fundraising plan under board consideration.

For shareholders, the critical linkage is the equity conversion feature across instruments. The company’s own disclosures highlight the scale of potential conversion shares tied to the FCCBs, and the July 28 agenda introduces an additional set of equity-linked possibilities via warrants and loan conversion.

What to watch next based on confirmed dates

The next confirmed milestone in the provided information is the board meeting scheduled for July 28, 2026, where the company will consider the proposed capital raise via convertible warrants or other eligible securities.

Investors will also track subsequent filings for details on the final structure of any warrants issuance and the specific terms and timeline of any loan-to-equity (or loan-to-warrants) conversion referenced in the July 28 context.